Markets · 1 sources covering this

City Therapeutics Raises $200 Million in Upsized US IPO

City Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·1h ago
City Therapeutics Raises $200 Million in Upsized US IPO
City Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/ed340a3a28aa616f06165fb108418926ea793635"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="City Therapeutics Raises $200 Million in Upsized US IPO"></iframe>

City Therapeutics Raises $200 Million in Upsized US IPO

How 1 sources are covering this

City Therapeutics Raises $200 Million in Upsized US IPO

More from Markets

Blue Owl: Private Credit Redemptions Are Falling

South Africa Court Rulings May Lift Confidence, PSG Chief Says

Fed Chair Warsh Says US Is Seeing an Investment Surge

Indonesia Stocks Sink as MSCI Weighs Index Removal

Reader

Trust & legal

Across the network